Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$4.92 0.06 (1.2%) as of 4:30 Wed 5/29


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 302.08(M)
Last Volume: 687,618 Avg Vol: 703,347
52 Week Range: $3.38 - $6.66
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 554
  Page 15 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Tang Capital Partners Lp 10% Owner   –       –       •   2009-10-13 4 S $12.76 $6,918,844 I/I (542,072) 3,123,780     -
   Karabelas Argeris N Director   –       •      –    2009-10-13 4 S $12.65 $3,004,375 I/I (237,500) 762,500     -
   Ramsay David Russ Director   –       •      –    2009-10-13 4 S $12.65 $3,004,375 I/I (237,500) 762,500     -
   Feeney John Joseph Acting Chief Medical Officer   •       –      –    2009-05-18 4 S $12.00 $78,744 D/D (6,562) 0     -
   Feeney John Joseph Acting Chief Medical Officer   •       –      –    2009-05-13 4 S $12.00 $36,000 D/D (3,000) 9,562     -
   Feeney John Joseph Acting Chief Medical Officer   •       –      –    2009-05-13 4 S $12.19 $36,637 D/D (3,000) 6,562     -
   Irish Stephanie Rast Sr. VP, Acting CFO/Treasurer   •       –      –    2009-05-13 4 S $12.00 $120,000 D/D (10,000) 2,449     -
   Feeney John Joseph Acting Chief Medical Officer   •       –      –    2009-05-12 4 S $10.11 $75,205 D/D (7,438) 12,562     -
   Irish Stephanie Rast Sr. VP, Acting CFO/Treasurer   •       –      –    2009-05-12 4 S $10.11 $76,347 D/D (7,551) 12,449     -
   Feeney John Joseph Acting Chief Medical Officer   •       –      –    2009-05-11 4 S $9.14 $45,704 D/D (5,000) 20,000     -
   Feeney John Joseph Acting Chief Medical Officer   •       –      –    2009-05-11 4 OE $0.00 $0 D/D 20,000 25,000     -
   Clark William D Sr. VP, Chief Business Officer   •       –      –    2009-05-11 4 OE $0.00 $0 D/D 25,000 75,000     -
   Irish Stephanie Rast Sr. VP, Acting CFO/Treasurer   •       –      –    2009-05-11 4 OE $0.00 $0 D/D 20,000 20,000     -
   Polymeropoulos Mihael Hristos Chief Executive Officer   •       •      –    2009-05-11 4 OE $0.00 $0 D/D 75,000 425,000     -
   Feeney John Joseph Chief Medical OfficerOfficer   •       –      –    2009-01-09 3 IO $0.00 $0 D/D 0 5,000     -
   Feeney John Joseph Chief Medical OfficerOfficer   •       –      –    2009-01-09 3 IO $0.00 $0 D/D 0 40,000     -
   Irish Stephanie Rast Sr. VP, CFO, TreasurerOfficer   •       –      –    2009-01-09 3 IO $0.00 $0 D/D 0 40,000     -
   Polymeropoulos Mihael Hristos Chief Executive Officer   •       •      –    2008-12-16 4 A $0.00 $0 D/D 150,000 500,000     -
   Clark William D Sr. VP, Chief Business Officer   •       –      –    2008-12-16 4 A $0.00 $0 D/D 50,000 100,000     -
   Tang Capital Partners Lp 10% Owner   –       –       •   2008-11-20 4 B $0.73 $105,531 I/I 145,000 3,665,852 1.5     -
   Tang Capital Partners Lp 10% Owner   –       –       •   2008-11-07 4 B $0.83 $464,296 I/I 560,000 3,520,852 1.5     -
   Tang Capital Partners Lp 10% Owner   –       –       •   2008-09-25 3 IO $0.00 $0 I/I 0 2,960,852     -
   Tang Capital Partners Lp 10% Owner   –       –       •   2008-09-25 4 B $1.04 $622,680 I/I 600,000 5,619,058 1.5     -
   Tang Capital Partners Lp 10% Owner   –       –       •   2008-09-23 4 B $0.98 $78,520 I/I 80,000 5,019,058 1.5     -
   Tang Capital Partners Lp 10% Owner   –       –       •   2008-09-22 4 B $1.00 $99,880 I/I 100,000 4,939,058 1.5     -
  554 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us